Celldex Therapeutics, Inc. — Director's Dealing 2016

Jun 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2016-06-03

Reporting Person: CATLIN AVERY W (Sr. VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-03	Common Stock, par value $0.001 per share	M	20000	$2.80	Acquired	70739	Direct
2016-06-03	Common Stock, par value $0.001 per share	M	2847	$4.50	Acquired	73586	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-03	Incentive Stock Option	$2.80	M	20000	Disposed	2021-08-05	Common Stock (20000)	Direct
2016-06-03	Incentive Stock Option	$4.50	M	2847	Disposed	2020-01-21	Common Stock (2847)	Direct

Footnotes

F1: As of August 5, 2015, the option is fully vested.

F2: As of January 21, 2014, the option is fully vested.